Skip to main content
Fig. 1 | BMC Palliative Care

Fig. 1

From: Communication of Pharmacogenomic test results and treatment plans in pediatric oncology: deliberative stakeholder consultations with parents

Fig. 1

Overview of the Deliberative Stakeholder Consultation Design. In Phase I, bereaved parents and parents of children with brain cancer currently in treatment attended separate 2–3 h small-group consultations, with the goal of identifying salient communication issues associated with the potential implementation of the LDT in practice. All participants in Phase I were subsequently invited to attend the Phase II mixed consultation, where parents co-created family-centered recommendations regarding the pediatric oncology team’s LDT-based communication approach

Back to article page

BMC Palliative Care

ISSN: 1472-684X

Contact us